Discovery of Potent Allosteric DRP1 Inhibitors by Disrupting Protein-Protein Interaction with MiD49

被引：2
|
作者：
Furuya, Takeru [1 ,2 ]
Lin, Jean [1 ,3 ]
Afanaseva, Arina [1 ,4 ]
Molz, Lisa [1 ,5 ]
Lagu, Bharat [1 ]
Ma, Bin [1 ,6 ]
机构：
[1] Mitobridge Inc, Cambridge, MA 02138 USA
[2] Xontogeny, Boston, MA 02116 USA
[3] Mitobridge, Astellas, Cambridge, MA 02138 USA
[4] Astellas, Adv Informat & Analyt, Tsukuba, Ibaraki 3058585, Japan
[5] AvilarTherapeutics, Waltham, MA 02451 USA
[6] ArtBio Inc, Cambridge, MA 02142 USA
来源：
ACS MEDICINAL CHEMISTRY LETTERS | 2023年 / 14卷 / 08期
关键词：
DRP1; MiD49; Protein-proteininteraction; Allosteric; inhibitor; Mitochondria; MITOCHONDRIAL DIVISION DYNAMIN; SMALL-MOLECULE INHIBITORS; FISSION; FUSION;
D O I：
10.1021/acsmedchemlett.3c00223
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Mitochondrialdysfunction has been attributed to many disease indications, includingmetabolic, cardiovascular, neoplastic, and neurodegenerative diseases.Dynamin related protein 1 (DRP1) is crucial in regulating mitochondrialfission and maintaining mitochondrial homeostasis. MiD49 is a dynamicperipheral protein receptor on the surface of the mitochondrial membranethat recruits DRP1 protein to induce mitochondrial binary fission.By targeting the protein-protein interaction of DRP1/MiD49,we have discovered a novel and potent allosteric DRP1 inhibitor thatinhibits mitochondria fragmentation in vitro. X-raycocrystal structure revealed that it locked the closed DRP1 conformationby induced dimerization.
引用
收藏
页码：1095 / 1099
页数：5
相关论文
共 50 条
  • [41] Discovery of Potent and Selective Allosteric Inhibitors of Protein Arginine Methyltransferase 3 (PRMT3)
    Kaniskan, H. Umit
    Eram, Mohammad S.
    Zhao, Kehao
    Szewczyk, Magdalena M.
    Yang, Xiaobao
    Schmidt, Keith
    Luo, Xiao
    Xiao, Sean
    Dai, Miao
    He, Feng
    Zang, Irene
    Lin, Ying
    Li, Fengling
    Dobrovetsky, Elena
    Smil, David
    Min, Sun-Joon
    Lin-Jones, Jennifer
    Schapira, Matthieu
    Atadja, Peter
    Li, En
    Barsyte-Lovejoy, Dalia
    Arrowsmith, Cheryl H.
    Brown, Peter J.
    Liu, Feng
    Yu, Zhengtian
    Vedadi, Masoud
    Jin, Jian
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (03) : 1204 - 1217
  • [42] Discovery of bioactive natural products of microbial origin as inhibitors of the PD-1/PD-L1 protein-protein interaction
    Domingo-Contreras, Elisabeth
    Tormo, Jose R.
    Gonzalez-Menendez, Victor
    Mackenzie, Thomas A.
    Martin-Serrano, Jesus
    Magiera-Mularz, Katarzyna
    Kitel, Radoslaw
    Reyes, Fernando
    Genilloud, Olga
    Fernandez-Godino, Rosario
    Ramos, Maria C.
    Castillo, Francisco
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 264
  • [43] Fragment-based drug discovery of triazole inhibitors to block PDEδ-RAS protein-protein interaction
    Chen, Danqi
    Chen, Yuehong
    Lian, Fulin
    Chen, Liu
    Li, Yanlian
    Cao, Danyan
    Wang, Xin
    Chen, Lin
    Li, Jian
    Meng, Tao
    Huang, Min
    Geng, Meiyu
    Shen, Jingkang
    Zhang, Naixia
    Xiong, Bing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 163 : 597 - 609
  • [44] Discovery of Inhibitors Targeting Protein-Protein Interaction between Bacterial RNA Polymerase and NusG as Novel Antimicrobials
    Zheng, Yingbo
    Kan, Cheuk Hei
    Tsang, Tsz Fung
    Liu, Yanpeng
    Liu, Tiankuang
    Tsang, Man Wai
    Lam, Long Yin
    Yang, Xiao
    Ma, Cong
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (18) : 16556 - 16575
  • [45] Discovery of a novel and potent TACC3 protein-protein interaction inhibitor targeting highly aggressive cancers
    Sahin, Ozgur
    Banoglu, Erden
    Lim, Chaemin
    Caliskan, Burcu
    Cruz, Emmanuel
    Stergiopoulos, Sotirios
    Vempati, Sridhar
    CANCER RESEARCH, 2023, 83 (07)
  • [46] Discovery and Biological Characterization of PRMT5:MEP50 Protein-Protein Interaction Inhibitors
    Asberry, Andrew M.
    Cai, Xinpei
    Deng, Xuehong
    Santiago, Ulises
    Liu, Sheng
    Sims, Hunter S.
    Liang, Weida
    Xu, Xueyong
    Wan, Jun
    Jiang, Wen
    Camacho, Carlos J.
    Dai, Mingji
    Hu, Chang-Deng
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (20) : 13793 - 13812
  • [47] Optimization beyond AMG 232: Discovery and SAR of sulfonamides on a piperidinone scaffold as potent inhibitors of the MDM2-p53 protein-protein interaction
    Wang, Yingcai
    Zhu, Jiang
    Liu, Jiwen
    Chen, Xiaoqi
    Mihalic, Jeff
    Deignan, Jeffrey
    Yu, Ming
    Sun, Daqing
    Kayser, Frank
    McGee, Lawrence R.
    Lo, Mei-Chu
    Chen, Ada
    Zhou, Jing
    Ye, Qiuping
    Huang, Xin
    Long, Alexander M.
    Yakowec, Peter
    Oliner, Jonathan D.
    Olson, Steven H.
    Medina, Julio C.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2014, 24 (16) : 3782 - 3785
  • [48] Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction
    Abed, Dhulfiqar Ali
    Lee, Sumi
    Hu, Longqin
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (06)
  • [49] New chemical tools for disrupting the Mcl-1/BH3 protein-protein interaction
    Pernazza, Daniele
    Doi, Kenichiro
    Lawrence, Harshani
    Sebti, Sayd
    Wang, Hong-Gang
    Lawrence, Nicholas
    CANCER RESEARCH, 2011, 71
  • [50] Novel regulatory roles of Mff and Drp1 in E3 ubiquitin ligase MARCH5-dependent degradation of MiD49 and Mcl1 and control of mitochondrial dynamics
    Cherok, Edward
    Xu, Shan
    Li, Sunan
    Das, Shweta
    Meltzer, W. Alex
    Zalzman, Michal
    Wang, Chunxin
    Karbowski, Mariusz
    MOLECULAR BIOLOGY OF THE CELL, 2017, 28 (03) : 396 - 410
12345